Literature DB >> 14997028

Role of apoptosis in autoimmunity.

Matilde Todaro1, Ann Zeuner, Giorgio Stassi.   

Abstract

Autoimmune diseases are characterized by the activity of autoreactive lymphocytes that produce antibodies targeting self tissue or organ for destruction. Although the pathogenesis of these diseases is poorly understood, during the past two decades basic research has indicated apoptosis as the pivotal molecular mechanism leading to autoimmunity. Recently cytokines have been invoked in the regulation of the apoptosis-related factors and death receptors in autoimmune target destruction. These research advances have contributed to the identification of mechanisms controlling autoimmunity for defining novel therapeutic strategies.

Entities:  

Mesh:

Year:  2004        PMID: 14997028     DOI: 10.1023/B:JOCI.0000018057.89066.c6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  160 in total

1.  Determinants of autoimmune thyroid disease.

Authors:  A P Weetman
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

2.  Autoimmune diseases: the failure of self tolerance.

Authors:  A A Sinha; M T Lopez; H O McDevitt
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

3.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

Review 4.  The Bcl-2 protein family: arbiters of cell survival.

Authors:  J M Adams; S Cory
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 5.  Animal models of autoimmunity and their relevance to human diseases.

Authors:  S Sakaguchi
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

Review 6.  Apoptosis genes and autoimmunity.

Authors:  D L Vaux; R A Flavell
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

Review 7.  New ideas in thyroid autoimmunity.

Authors:  R Pujol-Borrell; I Todd; M Londei; M Feldmann; G F Bottazzo
Journal:  Horm Res       Date:  1987

8.  Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.

Authors:  K S Ko; M Lee; J J Koh; S W Kim
Journal:  Mol Ther       Date:  2001-10       Impact factor: 11.454

9.  Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells.

Authors:  S Wesselborg; O Janssen; D Kabelitz
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

10.  Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.

Authors:  P Dowling; G Shang; S Raval; J Menonna; S Cook; W Husar
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  8 in total

1.  Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; K C R Malmegrim; A F Ferreira; R Tognon; S Kashima; C E B Couri; D T Covas; J C Voltarelli; F A de Castro
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

Review 2.  Advancing drug delivery systems for the treatment of multiple sclerosis.

Authors:  Inna Tabansky; Mark D Messina; Catherine Bangeranye; Jeffrey Goldstein; Karen M Blitz-Shabbir; Suly Machado; Venkatesh Jeganathan; Paul Wright; Souhel Najjar; Yonghao Cao; Warren Sands; Derin B Keskin; Joel N H Stern
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells.

Authors:  Hongwei Xu; Zhi-Ying Wu; Fang Fang; Lan Guo; Doris Chen; John Xi Chen; David Stern; Gregory A Taylor; Hong Jiang; Shirley ShiDu Yan
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

4.  Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis.

Authors:  Mehrdad Alirezaei; Howard S Fox; Claudia T Flynn; Craig S Moore; Andrea L O Hebb; Ricardo F Frausto; Virender Bhan; William B Kiosses; J Lindsay Whitton; George S Robertson; Stephen J Crocker
Journal:  Autophagy       Date:  2009-02-05       Impact factor: 16.016

5.  Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine.

Authors:  Zahra Ghanian; Sepideh Maleki; Hannah Reiland; Daniel E Bütz; Grazia Chiellini; Fariba M Assadi-Porter; Fariba-Assadi Porter; Mahsa Ranji
Journal:  Exp Biol Med (Maywood)       Date:  2013-12-03

6.  Altered regulatory mechanisms governing cell survival in children affected with clustering of autoimmune disorders.

Authors:  Loredana Palamaro; Giuliana Giardino; Francesca Santamaria; Ugo Ramenghi; Umberto Dianzani; Claudio Pignata
Journal:  Ital J Pediatr       Date:  2012-09-12       Impact factor: 2.638

7.  Effects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes.

Authors:  Andrea L O Hebb; Craig S Moore; Virender Bhan; George S Robertson
Journal:  Autoimmune Dis       Date:  2010-12-28

8.  Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease.

Authors:  Maria Klatka; Ewelina Grywalska; Agata Surdacka; Jerzy Tarach; Janusz Klatka; Jacek Roliński
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.